| Title: | Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins |
| Journal: | Human Genomics |
| Published: | 25 Mar 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38523305/ |
| DOI: | https://doi.org/10.1186/s40246-024-00596-7 |
| URL: | https://humgenomics.biomedcentral.com/counter/pdf/10.1186/s40246-024-00596-7 |
Publication 10054
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
PurposeCoding mutations in the Transthyretin (TTR) gene cause a hereditary form of amyloidosis characterized by a complex genotype-phenotype correlation with limited information regarding differences among worldwide populations.MethodsWe compared 676 diverse individuals carrying TTR amyloidogenic mutations (rs138065384, Phe44Leu; rs730881165, Ala81Thr; rs121918074, His90Asn; rs76992529, Val122Ile) to 12,430 non-carriers matched by age, sex, and genetically-inferred ancestry to assess their clinical presentations across 1,693 outcomes derived from electronic health records in UK biobank.ResultsIn individuals of African descent (AFR), Val122Ile mutation was linked to multiple outcomes related to the circulatory system (fold-enrichment = 2.96, p = 0.002) with the strongest associations being cardiac congenital anomalies (phecode 747.1, p = 0.003), endocarditis (phecode 420.3, p = 0.006), and cardiomyopathy (phecode 425, p = 0.007). In individuals of Central-South Asian descent (CSA), His90Asn mutation was associated with dermatologic outcomes (fold-enrichment = 28, p = 0.001). The same TTR mutation was linked to neoplasms in European-descent individuals (EUR, fold-enrichment = 3.09, p = 0.003). In EUR, Ala81Thr showed multiple associations with respiratory outcomes related (fold-enrichment = 3.61, p = 0.002), but the strongest association was with atrioventricular block (phecode 426.2, p = 2.81 × 10− 4). Additionally, the same mutation in East Asians (EAS) showed associations with endocrine-metabolic traits (fold-enrichment = 4.47, p = 0.003). In the cross-ancestry meta-analysis, Val122Ile mutation was associated with peripheral nerve disorders (phecode 351, p = 0.004) in addition to cardiac congenital anomalies (fold-enrichment = 6.94, p = 0.003).ConclusionsOverall, these findings highlight that TTR amyloidogenic mutations present ancestry-specific and ancestry-convergent associations related to a range of health domains. This supports the need to increase awareness regarding the range of outcomes associated with TTR mutations across worldwide populations to reduce misdiagnosis and delayed diagnosis of TTR-related amyloidosis.</p>
8 Authors
- Antonella De Lillo
- Gita A. Pathak
- Aislinn Low
- Flavio De Angelis
- Sarah Abou Alaiwi
- Edward J. Miller
- Maria Fuciarelli
- Renato Polimanti
1 Application
| Application ID | Title |
|---|---|
| 58146 | The causes and consequences of pleiotropy across the human phenome |
Enabling scientific discoveries that improve human health